For the treatment of superficial ocular infections involving the conjunctiva and/or cornea caused by organisms susceptible to erythromycin. For infants born to mothers with clinically apparent ...

Erythromycin (as base) 333mg, 500mg; del-rel tabs. Erythromycin acts by inhibition of protein synthesis by binding 50S ribosomal subunits of susceptible organisms. It does not affect nucleic acid ...